Techne Corporation, the Minneapolis-based biotechnology company that now does business under the “Bio-Techne” brand, recently announced that it’s investing $10 million CyVek, Inc.—and it might ...
Techne’s weak performance relative to the healthcare sector over the past year, Wall Street analysts remain strongly ...
Wondering if Bio-Techne at around $60 a share is a bargain in disguise or a value trap? This breakdown will walk you through what the numbers are really saying about the stock. Despite being down ...
Techne Corporation announced Thursday that Chief Financial Officer (CFO) Gregory Melsen will resign on February 3. Melsen served as the Minneapolis-based biotech company’s CFO since 2004 and recently ...
Deutsche Bank analyst Justin Bowers raised the firm’s price target on Bio-Techne (TECH) to $72 from $66 and keeps a Buy rating on the shares. The ...
A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated ...
Bio-Techne Corp. topped $1 billion in full-year sales for the first time, its latest results showed Thursday, and the Minneapolis-based life science firm said it is beginning a two-year leadership ...
RBC Capital on Tuesday upgraded Bio-Techne Corporation (NASDAQ:TECH), noting that recent end-market weakness has over-penalized one of the best assets in the life science and tools (LST) sector, ...
BERLIN (dpa-AFX) - Bio-Techne Corp. (TECH), a life sciences company, announced Tuesday that it has won a second claim of reverse engineering by Miltenyi Biotec B.V. & Co. KG, which may appeal the ...
Bio-Techne Corp. failed to get shareholder approval on its executive compensation plan. While the vote is nonbinding, a no vote is rare. Only 35% of shareholders supported the plan during the ...
Our press releases may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Such statements involve risks and uncertainties that may affect the actual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results